Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sgiordan@mdanderson.org
Inflammatory breast cancer is a rare but highly aggressive form of locally advanced breast cancer. Historically, this disease was uniformly fatal; however, with the advent of induction chemotherapy and carefully coordinated multimodality treatment, the prognosis of these patients has improved. This article reviews the clinical characteristics of inflammatory breast cancer and the recent advances in therapy.